Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02437708
Other study ID # S56810 (ML10723) B322201421941
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date September 2014
Est. completion date October 2020

Study information

Verified date November 2020
Source Universitaire Ziekenhuizen Leuven
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the impact of autologous 'leucocyte and platelet rich fibrin' (L-PRF) on the periapical bone healing and further root development of infected immature permanent teeth. In the test group regenerative endodontic procedure (REP) is performed with L-PRF as scaffold, in the control group REP without L-PRF is performed .


Description:

Regenerative endodontic procedures are biologically based procedures designed to restore function of a damaged and nonfunctioning pulp by stimulation of existing stem and progenitor cells present in the root canal and/or the introduction and stimulation of new stem and dental pulp progenitor cells into the root canal under conditions that are favorable to their differentiation and reestablishment of function. L-PRF has the potential advantage of creating a bioactive construct that stimulates the local environment for differentiation and proliferation of these stem and progenitor cells. We have designed this confirmatory study to test the hypothesis that the use of L-PRF in REP of infected permanent immature teeth will accelerate periapical bone healing and stimulate the root maturation.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date October 2020
Est. primary completion date August 2019
Accepts healthy volunteers No
Gender All
Age group 6 Years to 25 Years
Eligibility Inclusion Criteria: - Provision of Informed Consent - Permanent immature teeth with weak root canal walls (hopeless prognosis) - Patients younger than 25 years Exclusion Criteria: - - Unlikely to be able to comply with the study procedures, as judged by the investigator. - Patients older than 25 years - Deciduous teeth - Permanent (immature) teeth that can be treated by a "regular" root canal treatment/ apexification - Known or suspected current malignancy - History of chemotherapy within 5 years prior to study - History of radiation in the head and neck region - History of other metabolic bone diseases - A medical history that makes REP unfavorable - Involvement in the planning and conduct of the study - Previous enrolment in the present study

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
REP with L-PRF

REP

Biological:
stem and progenitor cells


Locations

Country Name City State
Belgium Megabite Dental Office Brussels
Belgium C-Endo Herent
Belgium Department of Oral Health Sciences, KU Leuven & Dentistry, University Hospitals Leuven Leuven
Belgium EndoVanGorp Rotselaar

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen Leuven

Country where clinical trial is conducted

Belgium, 

References & Publications (1)

Diogenes A, Michael AH, Teixeira FB, Hargreaves KM. An update on clinical regenerative endodontics. Endod Top. 2013;28:2-23.

Outcome

Type Measure Description Time frame Safety issue
Other On conebeam CT (tridimensional measuring): the amount of periapical bone healing, increase in root canal wall thickness and root canal length. (composite) 3 years
Other Patient related outcome, measured by a questionnaire 3 years
Other Patient related outcome, measured by a pain-scale 3 years
Other Microbial diversity in the infected immature root canal Q-PCR analysis intraoperative
Primary Amount of periapical bone healing, measured on intra-oral bidimensional radiographs. 3 years
Secondary Amount of root development or maturogenesis,by measuring: on intra-oral bidimensional radiographs: the increase in root canal wall thickness. 3 years
Secondary Amount of root development or maturogenesis,by measuring: on intra-oral bidimensional radiographs: the increase in root canal length. 3 years
See also
  Status Clinical Trial Phase
Withdrawn NCT03502135 - Efficacy of Tetracaine/Oxymetazoline Nasal Spray for Endodontic Treatment Phase 4
Completed NCT03635515 - Occurrence of Post-op Pain Following Gentlewave N/A
Completed NCT04211519 - Analysis of Bacterial Microbiome of Endodontically Infected Primary and Permanent Teeth N/A
Completed NCT06176378 - A Clinical and Radiographic Evaluation of Low-Level Diode Laser Full Pulpotomy in Vital Permanent Teeth N/A
Completed NCT03551587 - Comparison Between the Vibringe and the Conventional Needle N/A
Recruiting NCT03883295 - Evaluation of Clinical and Radiological Success of Vital Amputation Treatment N/A
Completed NCT04700995 - Postoperative Pain After Using NiTi Instruments N/A
Completed NCT03472456 - Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?
Completed NCT03802305 - Comparison of Osteocentral Versus Locoregional Anesthesia in Case of Mandibular Molar Pulpitis N/A
Active, not recruiting NCT04399135 - Accuracy of Pulp Sensibility Test on Teeth With Deep Periodontal Pocket N/A
Recruiting NCT04628845 - Endo-perio Lesion's Treatment With Using Diode Laser 940nm N/A
Completed NCT04228913 - Effect of Different Obturation Techniques on Postoperative Pain Phase 4